Literature DB >> 35524146

The feasibility of telehealth in the monitoring of head and neck cancer patients: a systematic review on remote technology, user adherence, user satisfaction, and quality of life.

Helbert Eustáquio Cardoso da Silva1,2, Glaucia Nize Martins Santos3, André Ferreira Leite3, Carla Ruffeil Moreira Mesquita3, Paulo Tadeu de Souza Figueiredo3, Cristine Miron Stefani3, Nilce de Santos Melo3.   

Abstract

OBJECTIVES: This systematic review aimed to analyze the use of telehealth in monitoring patients with head and neck cancer regarding the application used, user adherence to technology, user satisfaction, and user quality of life.
MATERIALS AND METHODS: A search strategy was developed using the PICO acronym and the terms "Head and Neck Cancer," "Telehealth," "Mobile Application," and "Supportive Care." A broad literature search was performed on PubMed, Cochrane Library, Scopus, Web of Science, Lilacs, and Embase databases and on grey literature through Open Grey, Google Scholar, and Jstor, for studies comparing the monitoring of head and neck cancer patients with telehealth apps to the monitoring performed in a traditional way at health units. No study design, publication status, publication time, or language restrictions were applied. Pairs of reviewers worked independently for study selection and risk of bias assessment. The protocol was registered in PROSPERO and the PRISMA checklist used for reporting the review.
RESULTS: We found 393 references in the databases, 325 after duplicate removal; 19 met the criteria for full-text reading; 08 studies were included for qualitative synthesis. Although there was heterogeneity regarding the technology used, the studies included showed that remote monitoring and/or self-management of symptoms through mobile applications was feasible for most patients, with satisfactory degrees of acceptability, satisfaction, usability, and adherence. The health-related quality of life improved with the use of remote technologies for telehealth, associated with low to moderate self-efficacy, higher personal control, and higher knowledge of health with clinically acceptable levels of accuracy compared to traditional clinical evaluation. Even when the data presented were not statistically significant, patients reported improvement in health-related quality of life after the intervention.
CONCLUSIONS: Telehealth monitoring through the use of remote technologies presents itself as an alternative way of educating and supporting patients during the treatment of Head and Neck Cancer (HNC). There is the need for a more user-friendly interface, adequate user experience assessment, and the concrete applicability of telehealth technologies for monitoring patients with HNC in order to legitimize the cost-effectiveness of developing long-term multicenter longitudinal studies term.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Head and neck cancer; Monitoring; Oral cancer; Systematic review; Telehealth

Mesh:

Year:  2022        PMID: 35524146     DOI: 10.1007/s00520-022-07109-z

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.359


  44 in total

1.  Influence of social support on health-related quality of life outcomes in head and neck cancer.

Authors:  Lucy Hynds Karnell; Alan J Christensen; Eben L Rosenthal; J Scott Magnuson; Gerry F Funk
Journal:  Head Neck       Date:  2007-02       Impact factor: 3.147

2.  Distress in spouses and patients after treatment for head and neck cancer.

Authors:  Irma M Verdonck-de Leeuw; Simone E Eerenstein; Mecheline H Van der Linden; Dirk J Kuik; Remco de Bree; C Rene Leemans
Journal:  Laryngoscope       Date:  2007-02       Impact factor: 3.325

Review 3.  Physical and psychosocial correlates of head and neck cancer: an update of the literature and challenges for the future (1996-2003).

Authors:  Q C P Ledeboer; L-A Velden; M F Boer; L Feenstra; J F A Pruyn
Journal:  Clin Otolaryngol       Date:  2005-08       Impact factor: 2.597

Review 4.  Head and Neck Cancer Survivorship: Learning the Needs, Meeting the Needs.

Authors:  Jolie Ringash; Lori J Bernstein; Gerald Devins; Colleen Dunphy; Meredith Giuliani; Rosemary Martino; Sara McEwen
Journal:  Semin Radiat Oncol       Date:  2018-01       Impact factor: 5.934

5.  Self-management interventions for cancer survivors: A systematic review and evaluation of intervention content and theories.

Authors:  Colleen A Cuthbert; Janine F Farragher; Brenda R Hemmelgarn; Qirui Ding; Geoffrey P McKinnon; Winson Y Cheung
Journal:  Psychooncology       Date:  2019-10-15       Impact factor: 3.894

Review 6.  Psychosocial interventions for patients with head and neck cancer: past, present, and future.

Authors:  Cherith J Semple; Kate Sullivan; Lynn Dunwoody; W George Kernohan
Journal:  Cancer Nurs       Date:  2004 Nov-Dec       Impact factor: 2.592

7.  Quality-of-life impact of participation in a head and neck cancer support group.

Authors:  Kalpesh T Vakharia; M Jafer Ali; Steven J Wang
Journal:  Otolaryngol Head Neck Surg       Date:  2007-03       Impact factor: 3.497

Review 8.  Self-management education interventions for patients with cancer: a systematic review.

Authors:  Doris Howell; Tamara Harth; Judy Brown; Cathy Bennett; Susan Boyko
Journal:  Support Care Cancer       Date:  2017-01-05       Impact factor: 3.603

9.  Quality of life scores predict survival among patients with head and neck cancer.

Authors:  Carrie A Karvonen-Gutierrez; David L Ronis; Karen E Fowler; Jeffrey E Terrell; Stephen B Gruber; Sonia A Duffy
Journal:  J Clin Oncol       Date:  2008-06-01       Impact factor: 44.544

Review 10.  Common oral complications of head and neck cancer radiation therapy: mucositis, infections, saliva change, fibrosis, sensory dysfunctions, dental caries, periodontal disease, and osteoradionecrosis.

Authors:  Herve Y Sroussi; Joel B Epstein; Rene-Jean Bensadoun; Deborah P Saunders; Rajesh V Lalla; Cesar A Migliorati; Natalie Heaivilin; Zachary S Zumsteg
Journal:  Cancer Med       Date:  2017-10-25       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.